TRIPLEMED
TripleMed is developing minimally invasive products against aneurysms, without the need for incisions. The first product fills the aneurysm and prevents blood from entering, whilst leaving a channel for the blood to flow through to reach the other arteries. This enables a better and longer-lasting solution to the problem of aortic aneurysms.
TRIPLEMED
Industry:
Biotechnology Health Care Product Research
Founded:
2011-01-01
Address:
Maastricht, Limburg, The Netherlands
Country:
The Netherlands
Website Url:
http://www.triplemedical.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
2 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Google GStatic Google Static Content Google Cloud Sectigo SSL
Similar Organizations
30 Technology
30 TECHNOLOGY is developing and defining new models of care by unlocking the potential of Nitric Oxide.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Aratana Therapeutics
Aratana Therapeutics develops innovative therapies for the animal health industry.
Benvenue Medical
Benvenue Medical is a biotech company developing innovative and minimally invasive surgical solutions for the treatment of spinal disorders.
BioSense Solutions
BioSense Solutions provides innovative and cost-effective solutions for monitoring and analyzing microbial growth.
Biotelliga
Biotelliga develops safe and sustainable solutions for the effective management of agricultural crop pests and diseases.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
KTN Ltd.
KTN makes innovation in the railways automation proposing a control system IntelHeat for fully automatic management of railway points.
Nfocus Neuromedical
Nfocus Neuromedical develops endovascular neurosurgery solutions for the treatment of intracranial aneurysms.
Niviron Inc.
Niviron Inc. works to lengthen human life by developing innovative technologies for the treatment of oncological illnesses.
Orexia
Orexia aims to develop orally administered orexin positive modulators for the treatment of neurological diseases.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Respiray
Respiray is developing innovative and sustainable products that help to protect people’s health with UV technology.
Current Employees Featured
Founder
Investors List
Chemelot Ventures
Chemelot Ventures investment in Series A - TripleMed
Limburg Business Development Fund (LBDF)
Limburg Business Development Fund (LBDF) investment in Series A - TripleMed
Official Site Inspections
http://www.triplemedical.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
